BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January

Day

• 1
• 2
• 5
• 6
• 7
• 8

• Press Releases

  BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle (SPV) Transaction to Advance Ozuriftamab Vedotin (Oz-V) into a Registrational Trial for 2L+ Oropharyngeal Squamous Cell Carcinoma (OPSCC)

  January 1, 2026

   · 

  12 min read
• Press Releases

  Axsome Therapeutics Announces FDA Acceptance and Priority Review of Supplemental New Drug Application for AXS-05 for the Treatment of Alzheimer’s Disease Agitation

  January 1, 2026

   · 

  7 min read
• Press Releases

  Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-12 in Narcolepsy Supporting NDA Submission

  January 1, 2026

   · 

  7 min read
• Press Releases

  Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 31, 2025

  January 1, 2026

   · 

  3 min read
• Press Releases

  Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins

  January 1, 2026

   · 

  7 min read
• Press Releases

  Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism

  January 1, 2026

   · 

  3 min read
• Press Releases

  Novo Nordisk A/S: China’s Supreme People’s Court delivers a positive ruling on the semaglutide compound patent

  January 1, 2026

   · 

  2 min read
• Press Releases

  Alvotech Secures Term Loan Facility of USD 100 Million

  January 1, 2026

   · 

  5 min read
• Press Releases

  Clearmind Medicine Regains Compliance with Nasdaq Minimum Bid Price Requirement

  January 1, 2026

   · 

  4 min read
• Press Releases

  Modular Medical Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Rule

  January 1, 2026

   · 

  3 min read